Crossmark

Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials

Crossref DOI link: https://doi.org/10.1186/s12888-025-06696-5

Published Online: 2025-03-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohammed, Hazem E.

Gomaa, Menna A.

Khalifa, Youssef Magdy

Shawky, Ahmed Ayman
Funding

Funding for this research was provided by:

Assiut University
License Information

Text and Data Mining valid from 2025-03-31

Version of Record valid from 2025-03-31
More Information

Article History

Received: 4 February 2025

Accepted: 10 March 2025

First Online: 31 March 2025

Declarations

:

: Not applicable.

: Our manuscript was not applied to human beings and thus requires no ethical approval.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below